We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $71.3B
1-Year Est. Return 56.8%
This Fund
S&P 500
This Quarter Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
Cap. Flow
-$2.43B
Cap. Flow %
-3.41%
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$353M
2
MRVL icon
Marvell Technology
MRVL
+$150M
3
SYRE icon
Spyre Therapeutics
SYRE
+$126M
4
BBIO icon
BridgeBio Pharma
BBIO
+$116M
5
DOV icon
Dover
DOV
+$110M

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$713M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$355M
3
CTRA
Coterra Energy
CTRA
+$289M
4
RPRX icon
Royalty Pharma
RPRX
+$259M
5
LLY icon
Eli Lilly
LLY
+$236M

Sector Composition

Rank Sector Weight
1 Technology 32.29%
2 Healthcare 14.03%
3 Financials 12.39%
4 Industrials 8.94%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRMR icon
1051
Larimar Therapeutics
LRMR
$402M
– –
-300,000
Closed -$1.35M
MDGL icon
1052
Madrigal Pharmaceuticals
MDGL
$12.6B
– –
-185,331
Closed -$97M
MDU icon
1053
MDU Resources
MDU
$4.12B
– –
-500,000
Closed -$10.4M
MMSI icon
1054
Merit Medical Systems
MMSI
$5.21B
– –
-140,000
Closed -$9.65M
MP icon
1055
MP Materials
MP
$9.67B
– –
-30,000
Closed -$1.45M
NJR icon
1056
New Jersey Resources
NJR
$5.43B
– –
-60,000
Closed -$3.3M
NMRA icon
1057
Neumora Therapeutics
NMRA
$225M
– –
-1,000,000
Closed -$1.95M
NVGS icon
1058
Navigator Holdings
NVGS
$1.39B
– –
-695,000
Closed -$13.4M
OCS icon
1059
Oculis Holding
OCS
$637M
– –
-833,209
Closed -$22.2M
OLMA icon
1060
Olema Pharmaceuticals
OLMA
$906M
– –
-275,000
Closed -$4.1M
ONB icon
1061
Old National Bancorp
ONB
$9.72B
– –
-605,000
Closed -$13.4M
PENN icon
1062
PENN Entertainment
PENN
$2.3B
– –
-284,008
Closed -$4.27M
PGEN icon
1063
Precigen
PGEN
$2.43B
– –
-846,000
Closed -$3.27M
PK icon
1064
Park Hotels & Resorts
PK
$3.08B
– –
-100,000
Closed -$1.05M
PNFP icon
1065
Pinnacle Financial Partners Inc
PNFP
$15B
– –
-47,383
Closed -$4.08M
PRIM icon
1066
Primoris Services
PRIM
$3.98B
– –
-35,192
Closed -$5.03M
PSNL icon
1067
Personalis
PSNL
$1.75B
– –
-300,000
Closed -$1.91M
PTGX icon
1068
Protagonist Therapeutics
PTGX
$9.39B
– –
-282,436
Closed -$29.8M
QRVO icon
1069
Qorvo
QRVO
$9.28B
– –
-434,311
Closed -$33.6M
REPL icon
1070
Replimune Group
REPL
$1.36B
– –
-307,368
Closed -$2.35M
REXR icon
1071
Rexford Industrial Realty
REXR
$8.27B
– –
-47,135
Closed -$1.54M
RHP icon
1072
Ryman Hospitality Properties
RHP
$8.45B
– –
-176,312
Closed -$16.3M
RJF icon
1073
Raymond James Financial
RJF
$33.8B
– –
-123,150
Closed -$17.8M
SAIA icon
1074
Saia
SAIA
$9.22B
– –
-51,000
Closed -$17.9M
SEM
1075
DELISTED
Select Medical
SEM
– –
-658,467
Closed -$10.7M
41 42
43
44 45

Similar funds

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $70.2B AUM 30.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Adage Capital Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.

  • Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
  • Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
  • Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
  • Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
  • Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
  • Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
  • Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.